日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SMYD3 synergises with RACK1 to promote colorectal cancer lung metastasis by recruiting SMAD3.

SMYD3 与 RACK1 协同作用,通过募集 SMAD3 促进结直肠癌肺转移。

Bai Xiaoming, Han Dong, Chen Jie, Sheng Siqi, Feng Haimei, Wang Hongyu, Xu Ke, Huang Yadi, Huang Mengxi, Chu Xiaoyuan, Chen Yitian, Lei Zengjie

A novel molecule ZYZ329 targeting histone methyltransferase SMYD3 suppresses pathological angiogenesis via the driven mitochondrial ROS/HIF-1α/VEGFA axis.

一种靶向组蛋白甲基转移酶 SMYD3 的新型分子 ZYZ329 通过线粒体 ROS/HIF-1α/VEGFA 轴抑制病理性血管生成。

Ye Qing, Cai Jianghong, Lu Xianneng, Zhu Qi, Li Qixiu, Ren Mi, Ding Qian, Mao Yicheng, Zhu Yi Zhun

Macrophage-Derived Transcriptional Signatures Predict Prognosis and Drug Sensitivity in Thyroid Cancer: Integrative Analysis and Experimental Validation of SMYD3.

巨噬细胞衍生的转录特征预测甲状腺癌的预后和药物敏感性:SMYD3 的整合分析和实验验证。

Xu Sufang, Zhang Xin, Sun Jingru, Qin Man, Du Huarong, Luo Bing

SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1-Mediated Transactivation of CD47.

SMYD3 通过 SREBP1 介导的 CD47 反式激活促进透明细胞肾细胞癌的免疫逃逸。

Liu Zhengfang, Zhao Xiumei, Zang Maolin, Yuan Huiyang, Qin Xin, Li Xiaofeng, Zhao Shuo, Tan Ruirong, Yan Keqiang, Liu Li, Fan Yidong, Zhang Ning, Shi Benkang, Han Bo, Chen Shouzhen

Direct lysine dimethylation of IRF3 by the methyltransferase SMYD3 attenuates antiviral innate immunity

甲基转移酶SMYD3对IRF3的赖氨酸直接二甲基化可减弱抗病毒先天免疫反应。

Wang, Zixuan; Chen, Xiaoyun; Zhu, Chunchun; Fan, Sijia; Tang, Jinhua; Deng, Hongyan; Sun, Xueyi; Liu, Xing; Xiao, Wuhan

Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy

SMYD3-SHCBP1的致癌激活促进乳腺癌的发生发展,并与免疫治疗耐药性相关。

Lihua Mo ,Min Deng ,Ragini Adhav ,Yuni Chan ,Josh Haipeng Lei ,Sek Man Su ,Xin Zhang ,Tingting An ,Jianlin Liu ,Jianjie Li ,Xiaodong Shu ,Jun Xu ,Yuqing Wang ,Lin Chen ,Yan-Gao Man ,Ning-Yi Shao ,Tingxiu Xiang ,Chu-Xia Deng ,Xiaoling Xu

USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment

USP15 通过 SMYD3/CCL2 依赖性髓系来源抑制细胞募集促进结直肠癌免疫逃逸

Shuling Han #,Luying Cui #,Bojun Wang #,Yuli Ruan,Mengde Shi,Chang Hong,Xin Guan,Zhuo Chen,Yingjue Li,Yuanyu Liao,Ming Ma,Xiaolin Lu,Hong Wang,Yanqiao Zhang,Chao Liu

The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis

转录因子HOXA9诱导染色质修饰因子SMYD3的表达,从而驱动白血病发生。

Liping Zhang ,Jinqiu Zhong ,Luo Yang ,Qianyun Ye ,Yanli Jin ,Chang Liu ,Peilong Lai ,Hongle Li ,Jingxuan Pan ,Bei Jin

SMYD3-CDCP1 Axis Drives EMT and CAF Activation in Colorectal Cancer and Is Targetable for Oxaliplatin Sensitization

SMYD3-CDCP1轴驱动结直肠癌中的EMT和CAF活化,并可作为奥沙利铂增敏的靶点

Liming Zhao,Zhexue Wang,Pu Cheng,Guoli Sheng,Mingyu Han,Zhaoxu Zheng

Lysine Methyltransferases SMYD2 and SMYD3: Emerging Targets in Kidney Diseases

赖氨酸甲基转移酶SMYD2和SMYD3:肾脏疾病的新兴靶点

Du, Xinyu; Yao, Liyuan; Zhuang, Shougang